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Abstract 
Background: Multimorbidity and polypharmacy are common challenges in the treatment of older trauma patients. 
Therefore, various integrated care models were developed over the last few years, merging the expertise of geri-
atricians and trauma surgeons. The aim of this study was to evaluate, if the number of prescriptions of potentially 
inappropriate medication (PIM) could be reduced in these patients by an interdisciplinary co-managed concept 
compared to conventional trauma care.
Methods: We conducted a retrospective, dual-center cohort study, including all patients aged 70 years and older 
admitted with a fracture of the hip or the proximal humerus within the study period. Patients were treated in the 
universities department of trauma surgery with two different hospital sites, one with conventional trauma care (CTC) 
and the other one with a certified orthogeriatric trauma unit (OGC). Based on the STOPP/START criteria by O´Mahony 
et al., PIMs were defined, which should be avoided in (ortho)geriatric patients. Medical records of each patient were 
analyzed at discharge. Besides patients basic information, all prescribed drugs, changes in the medication plan and 
who carried out these changes were collected. For statistical analysis based on the data quality and distribution, the t 
test, Mann–Whitney U test and the Chi-square test were used.
Results: A total of 95 patients were included, 73 of them females, with an average age of 82.59 years (SD ± 6.96). 
Mean length of hospital stay was 12.98 at CTC and 13.36 days at OGC (p = 0.536). Among conventional care (41 
patients), prescription of one or more PIMs was found in 85.4% of the patients, whereas at the orthogeriatric ward (54 
patients) only in 22.2% (p < 0.001). Besides that, changes in medication were made for 48.1% of the patients during 
their stay on the orthogeriatric ward.
Conclusions: Our findings show that an integrated care concept can reduce the number of prescriptions of PIMs 
significantly and potentially avoids adverse drug reactions and additional burdens in older trauma patients.
Keywords: Integrated care, Hip fracture, Humeral fracture, Pharmacotherapy, Frailty
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
European Journal
of Medical Research
*Correspondence:  carl.neuerburg@med.uni-muenchen.de 
1 Department of General, Trauma and Reconstructive Surgery, University 
Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany
Full list of author information is available at the end of the article
Page 2 of 7Gleich et al. Eur J Med Res            (2019) 24:4 
Background
The number of older trauma patients is expected to 
increase in the next years, with hip and humeral fractures 
as two of the most frequent fractures in these patients [1]. 
For hip fractures, a global increase up to 6.3 million/year 
until 2050 is stated [2]. Besides the fracture itself, frailty, 
multimorbidity and resulting polypharmacy (up to 44% 
of patients at an age of 65 years or older) bring additional 
difficulties for patients as well as for trauma surgeons and 
their team [3, 4]. Especially in the early phase of injured 
older patients and those undergoing surgery, vulner-
ability is very high and the use of potential inappropri-
ate medication (PIM) could further worsen this situation. 
Poor outcomes with mortality rates up to 25–30% in the 
first year after hip fracture, nearly 10% one  year after 
humeral fracture and a decrease in the abilities for activi-
ties of daily living are common [5–7]. Gosch et  al. [8] 
could show the impact of medications on the long-term 
outcome of older hip fracture patients; thus, prescription 
of one PIM leads to an increased relative risk of mortality 
by 28%. Regarding to Laboni et al. [9] with 51% of their 
older patients receiving at least one PIM, prescription 
of PIMs was common after hip fracture surgery and was 
associated with a longer time to achieve full recovery. 
These results are also seen in other surgical specialties 
like general-, gynecological- und urogenital surgery with 
prescription of PIMs in 19–23% of older patients under-
going surgery [10]. Although these difficulties are well 
known, there is still disagreement about the best way of 
treatment for older trauma patients. Four different care 
models are described, firstly a trauma ward with con-
sultation of a geriatrician on demand, secondly trauma 
wards with regular consultation by a geriatrician, thirdly 
a geriatric ward with regular consultation by a trauma 
surgeon and the fourth, most intensive model of an 
orthogeriatric ward with interdisciplinary management, 
which represents the highest level of co-management 
[11, 12]. By now, this co-managed model, where trauma 
surgeons and geriatricians work together on a specifically 
designed ward with a specialized team of nurses, physi-
otherapists and many others, remains the most effec-
tive approach, which showed improvements in mortality 
rates, mobility and independency [13–15].
Therefore, the present study was performed based 
on the hypothesis that an interdisciplinary treatment 
reduces PIMs in older adult trauma patients.
Methods
We conducted a retrospective, dual-center cohort 
study at a level I trauma center. The clinic has two dif-
ferent sites, one with conventional trauma care (CTC) 
(49 beds) and the other with a certified orthogeriatric 
unit (OTC) (44 beds), where the patients are treated in 
an interdisciplinary manner such as the complex ward 
model described by Pioli [11].
Thus, permanent integration of the geriatrician into 
the trauma team was granted, including daily interdisci-
plinary ward rounds (except on weekends, as there is no 
geriatrician at service and consultation of specialists of 
internal medicine is provided on demand) of each ortho-
geriatric patient and considering all elements of ortho-
geriatric care (according to Lisk et  al.) [16]. Integration 
starts with the inpatient admission and ends at discharge. 
Medication was checked by the geriatrician at admission 
to hospital (medication plan brought by patient, inter-
view with patient/relatives/general practitioner), at the 
daily interdisciplinary meeting of the orthogeriatric team 
and at discharge. PIMs were defined, which should be 
avoided in older trauma patients, based on the STOPP/
START criteria presented by O´Mahony et  al. and the 
PRISCUS list by Holt et al. (Table 1) [17–19].
At the conventional trauma ward, treatment was 
managed by trauma surgeons with no specific geriat-
ric expertise, following the current guidelines and other 
departments were consulted in case of need.
All consecutive patients aged 70  years and older, who 
were admitted due to a fracture of the hip or the humerus 
from 07/2016 until 09/2016, were included. There were 
no other in- or exclusion criteria, to give a realistic view 
of the patient collective. The study was approved and 
registered by the local ethics committee of Munich uni-
versity (Reg. No. 234-16); no informed consent had to be 
obtained because of retrospective data collection. Demo-
graphic data and important values for medication (glo-
merular filtration rate (GFR), creatinine level, vitamin D 
level, Charlson Comorbidity Index, ASA score, time to 
surgery) were collected from the hospital information 
system and checked for comparability of the two groups. 
After discharge, medical records of each patient were 
analyzed, especially information about basic medication 
at admission, changes in the medication plan while their 
hospital stay including the person, who carried out these 
changes (geriatrician or trauma surgeon) and medication 
at discharge were collected.
Primary outcome parameters were the number of pre-
scription of PIMs, changes in the medication plan and 
start of an osteoporosis treatment as secondary outcome.
All data were merged in a special built data sheet (Excel 
2011, Version 14.0 for Mac OS X, Microsoft Cooperation, 
Redmond).
Data were reported as mean ± standard deviation, 
categorical data as absolute frequency with a percent-
age distribution. Chi-square test was used for statistical 
analysis of categorical variables; t test and Mann–Whit-
ney test were used depending on data distribution. A p 
value < 0.05 was stated as statistically significant. IBM 
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SPSS Statistics for Macintosh, Version 24 (IBM Corp. 
Released 2016. Amonk, NY) was used for the statistical 
analysis.
Results
A total of 95 patients were included, 77% (73) of them 
were females. Table  2 shows baseline characteristics of 
the patients. No statistically significant differences were 
found in between the two groups except gender (Table 2). 
Prescription of a PIM was registered in 85.4% (35 of 41 
patients) at the conventional trauma ward and in 22.2% 
(12 of 54 patients) at the orthogeriatric ward (p < 0.001) 
(Fig. 1). Frequency of distribution of the most used drugs 
is shown in Fig. 2.
While on the conventional trauma ward no adjustment 
of medication during hospital stay was observed, 48.1% 
(26 of 54 patients) of the patients on the orthogeriatric 
ward received an adjustment by the geriatrician.
Preexisting osteoporosis medication was registered in 
19.5% (n = 8) of the patients with conventional and 16.7% 
(n = 9) with integrated care (p = 0.72). During their stay 
in hospital, diagnostic evaluation of osteoporosis status 
(blood values and bone density measurement) was per-
formed in 41.5% (n = 17) with conventional and 42.6% 
(n = 23) of the patients with orthogeriatric treatment.
No significant difference regarding cognitive impair-
ment at admission was observed (CTC: 17.1%, n = 7; 
OGC: 14.8%, n = 8; p = 0.765).
Discussion
Orthogeriatric patients frequently present with poly-
pharmacy (up to 44% as mentioned above) and are 
prone to secondary complications arising from poten-
tial inappropriate drug prescription. Certain drugs are 
particularly hazardous in these patients, such as benzodi-
azepines which can potentially cause confusion, delirium 
and further cognitive disorders. The present study aimed 
to evaluate differences in the prescription habits in older 
trauma patients undergoing an interdisciplinary co-man-
aged care compared to patients being treated by conven-
tional trauma care, without any input by a geriatrician, in 
a level-one department of trauma surgery with two dif-
ferent hospital sites.
An additional input to conduct the present study was 
the case of an 86-year-old female who was treated on 
our orthogeriatric ward. The patient was admitted with 
a proximal femoral fracture, various comorbidities and, 
therefore, an intake of numerous drugs. Given two dif-
ferent concentrations and product names of two existing 
lithium dosages, the preexisting medication was mis-
takenly adopted and transferred by the staff. During her 
stay in hospital, increasing creatinine blood levels were 
observed, which were discussed on the daily interdiscipli-
nary ward round with our geriatrician. After controlling 
medication and additional blood values, a lithium intoxi-
cation was found, which was previously not detected by 
the surgeons and medication was subsequently paused 
for the in-hospital period; renal function recovered 
within a few days.
Table 1 Most relevant PIMs in orthogeriatric setting
Drug Reason
NSAID
(Ibuprofen, Diclofenac, Aspirin)
Increased risk for: gastrointestinal ulcer, myocardial infarction (MI), stroke, hypertensive 
crisis, impaired renal function
Benzodiazepines Increased risk for sedation, delirium, falls
Tricyclic antidepressants at preexisting dementia Increased risk for delirium, falls, urinary retention, cardiac arrythmia
Opiates (long acting) at preexisting dementia Cognitive worsening
Antimuscarinic drugs at preexisting dementia Cognitive worsening
Neuroleptics (long acting) at preexisting Parkinson´s disease Cognitive worsening
SSRI-type antidepressants at hyponatremia Cognitive worsening, increased risk of falls, negative effect on bone metabolism
Antibiotics
 Gyrase inhibitors
 Gentamicin
Increased risk for:
 QT extension, seizure, dizziness, confusion, tendon rupture
 Renal failure, ototoxicity
Antihistamines (especially H1) Increased risk for: constipation, dizziness, cognitive impairment
Statins (except at preexisting MI, coronary heart disease, stroke) Muscle weakness, increased risk for rhabdomyolysis
Urologicals/incontinence medication (except indispensable) Increased risk for: cognitive worsening, falls
Glucocorticoids (except indispensable) Confusion, negative effect on bone metabolism
Digitalis (except indispensable) Cardiac arrythmia
Diuretics (except indispensable, e.g., at renal insufficiency) Increased risk for: dizziness, dehydration, confusion, electrolyte imbalance
Specific antihypertensive drugs (clonidine, reserpine, proprano-
lol, hydralazine)
Increased risk for: cognitive impairment, depression, orthostatic hypotension, sedation
Page 4 of 7Gleich et al. Eur J Med Res            (2019) 24:4 
Table 2 Baseline characteristics
CTC (n = 41) OGC (n = 54) p value
Age (years), mean (SD) 81.54 (± 6.91) 83.39 (± 6.959) 0.201
Gender (female) 87.8% (n = 36) 68.5% (n = 37) 0.027
ASA score 0.406
 1–2 29.3% (n = 12) 22.2% (n = 12)
 3 68.3% (n = 28) 74.1% (n = 40)
 4–5 2.4% (n = 1) 3.7% (n = 2)
Charlson comorbidity index, mean (SD) 2.51 (± 1.989) 2.09 (± 1.733) 0.281
Length of stay (days), mean (SD) 12.98 (± 4.43) 13.36 (± 5.516) 0.536
Proximal humerus 11.00 (3.661) 10.00 (6.453) 0.656
Femoral 13.70 (4.519) 14.67 (4.817) 0.392
Type of fracture 0.440
 Proximal humerus 26.8% (n = 11) 22.2% (n = 12)
 Femoral
  Trochanteric 29.3% (n = 12) 29.6% (n = 16)
  Femoral neck 41.5% (n = 17) 37.0% (n = 20)
  Periprosthetic 2.4% (n = 1) 11.1% (n = 6)
Type of treatment 0.218
 Femoral
  Osteosynthesis 50.0% (n = 15) 50.0% (n = 21)
  Prosthesis 50.0% (n = 15) 50.0% (n = 21)
 Humeral
  Osteosynthesis 54.5% (n = 6) 91.7% (n = 11)
  Prosthesis 45.5% (n = 5) 8.3% (n = 1)
Time to surgery
 Femoral 0.134
  < 24 h 93.3% (n = 28) 81.0% (n = 34)
  24 h 6.7% (n = 2) 19.0% (n = 8)
 Humeral 0.901
  < 24 h 27.3% (n = 3) 25.0% (n = 3)
  > 24 h 72.7% (n = 8) 75.0% (n = 9)
GFR (ml/min) 66.93 (± 19.865) 69.93 (± 21.474) 0.496
Creatinine (mg/dl) 0.945 (± 0.357) 1.11 (± 0.453) 0.056
Vit. D 0.213
 < 20 ng/ml 69.2%(n = 18) 84.4% (n = 27)
 > 20 ng/ml 30.8%(n = 8) 15.6%(n = 5)
 Not stated n = 15 n = 22
Discharged to
 Femoral 0.777
  Own home 13.3% (n = 4) 14.3% (n = 6)
  Nursing home 10.0% (n = 3) 4.8% (n = 2)
  Rehabilitation unit 63.3% (n = 19) 71.4% (n = 30)
  Short-term nursing 13.3% (n = 4) 9.5% (n = 4)
 Humeral 0.169
  Own home 72.7% (n = 8) 58.3% (n = 7)
  Nursing home 0% (n = 0) 16.7% (n = 2)
  Rehabilitation unit 9.1% (n = 1) 25.0% (n = 3)
  Short-term nursing 18.2% (n = 2) 0% (n = 0)
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Regarding the number of prescriptions of PIMs, a sig-
nificant difference between orthogeriatric and conven-
tional trauma care was observed in the present study. 
Patients treated on an orthogeriatric ward received a 
more cautious prescription of medication as those pri-
marily treated by surgeons. This might be attributed to 
various factors. At first, careful re-evaluation of patients 
medical records by the geriatrician at admission to the 
orthogeriatric ward, where the preexisting medication 
plan, which might already include inappropriate pre-
scriptions, is checked. This procedure is also carried out 
by the staff on the conventional trauma ward, but they 
may not have the specific geriatric expertise in interac-
tion of various pharmaceuticals and their effect on older 
patients. Secondly, daily interdisciplinary ward rounds 
and discussions of each patient at OGC help to manage 
upcoming difficulties like postoperative delirium and 
find the right medication in conjunction with the current 
medication plan. This is represented by registered adjust-
ments to the medication by the geriatrician in almost half 
of the patients at OGC. Thus, significantly more changes 
during hospital stay were observed on the OGC com-
pared to those treated with CTC. There may also be a 
learning process for trauma surgeons on an OGC. Con-
sistent input of the geriatrician improves the surgeons 
understanding for the risk of adverse drug reactions and 
how to avoid them as shown previously [20].
Regarding fracture treatment, no difference between 
the two hospital sites was observed. The data suggest that 
there was no relevant influence of the geriatrician to the 
surgical treatment plan in the early stage. This might be 
explained by the time when the geriatrician is involved in 
the interdisciplinary team. At OGC, this is usually short 
after surgery and only few situations might result in an 
earlier involvement. In frail patients with more complex 
fracture patterns, geriatricians might be involved earlier 
to give additional input for choosing a specific surgical 
procedure or decline surgery in individual cases.
Regarding secondary fracture prevention, both hospital 
sides provide a fracture liaison service (FLS), which coor-
dinates diagnostics, treatment initiation and continu-
ity for an underlying osteoporosis. Patients who suffer a 
fragility fracture and present with special risk factors for 
an osteoporosis are included and guideline adapted treat-
ment is recommended [21]. Therefore, the detected rate 
of osteoporosis assessments is comparable in both hos-
pital sites.
The importance of secondary fracture prevention is 
also highlighted by a study of Ryg et  al. [22] who could 
show recurrent fractures following primary hip frac-
ture. Besides the FLS approach to improve bone quality 
and prevent fragility fractures, this includes adjustment 
of medication to decrease induced symptoms like dizzi-
ness, which is often followed by falls and removal of fall 
Fig. 1 Use of PIMs: Illustration of the use of PIMs in either OGC- or 
CTC-treated patients
Fig. 2 Distribution of PIMs: see Table 1 for detailed description of each group of drugs/their adverse effects
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risk-increasing drugs. Negative side effects of the most 
frequently used PIMs according to the STOPP/START 
criteria are as follows. Antibiotics like gyrase inhibi-
tors and diuretics increase the risk of dizziness [23–25], 
although a use was observed in less than 10% of the 
patients treated with CTC. Benzodiazepines and opioids 
are frequently used in the pre- and postoperative stage 
and of undisputed benefit for anxiety and pain relief, 
yet they should be stopped as soon as possible because 
of their large potential to induce falls and therefore 
their impact on mortality [26–28]. Numerous studies 
on NSAIDs show their negative impact on cardiovascu-
lar system and the increased risk for major bleedings, 
despite intake of proton-pump inhibitors [29, 30]. They 
appeared to be the major proportion of PIMs detected in 
both CTC- and OGC-treated patients, which also might 
be associated with their beneficial effect, i.e., for the 
prophylaxis of periarticular ossification in hip fracture 
patients.
Although the surgical treatment remained compara-
ble, which is a strength of the study for the interpreta-
tion of the input arising from the geriatrician, it contains 
some limitations. Given the retrospective study design, 
there might have been inconsistent documentation of 
prescribed and discontinued drugs, which could distort 
our findings. Also, only the detection of PIMs was evalu-
ated, while further investigation if the hazardous effect 
of the individual prescription occured, was refrained. On 
the other side, bias of the prescription habits of the staff 
was excluded, while a prospective study design might 
be accompanied by specific attention of the staff, which 
could affect analysis. Another aspect of interest, which 
could not be reliably obtained, is patients’ medication at 
admission. Evaluation of the preexisting medication plans 
of each study center revealed that there was inconsistent 
documentation, which is partly attributed to the patients’ 
cognition or medication plans were forgotten back home 
by either the patients themselves or the ambulance ser-
vice. This would have given a better perspective on the 
impact of the geriatrician on PIM from admission to dis-
charge and should be considered for following prospec-
tive studies on that topic.
It would also be of interest for further studies to assess 
the impact of geriatricians in older trauma patients pre-
senting with a fracture usually requiring a shorter stay in 
hospital, like a distal radius fracture. In these cases, the 
impact of the geriatrician might be limited. Although the 
interdisciplinary co-managed concept might not be fea-
sible for every hospital due to personal limitations of the 
staff on trauma wards, further education of trauma sur-
geons with regards to selected drug prescriptions is rec-
ommended, given the findings of the present study and 
increasing numbers of elderly trauma patients.
Conclusion
Integration of a geriatrician into a trauma ward has shown 
significant benefits for older trauma patients. Despite 
already-known positive impact on mortality, preserva-
tion of independency, activities of daily living and mobil-
ity, reduced prescriptions of PIMs, improved selection of 
medication and an increased awareness for orthogeriatric 
patients were observed.
Especially, more fall risk-increasing drugs like benzodi-
azepines and medication causing dizziness were recorded 
in patients treated with CTC compared to prescriptions 
at OGC. Consequently, cautious selection of medica-
tion in older trauma patients is likely to prevent adverse 
drug reactions and reduce hazardous complications and 
may improve the long-term outcome. Regarding second-
ary fracture prevention, this is a key factor besides reliable 
osteoporosis evaluation and management to reduce fragil-
ity fractures.
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